Home › Osteosarcoma › Oregon
Osteosarcoma clinical trials in Oregon
4 studies for Osteosarcoma are looking for participants at sites in Oregon.
Cities in Oregon
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Oregon Health and Science University, Portland
RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Nov 12, 2026 · NCT04616560Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- Randall Children's Hospital, Portland
RecruitingPhase 2
Ages 0 to 50 · All sexes · Updated Oct 6, 2026 · NCT07321912Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.